Objective(s): Eukaryotic translation initiation factor 4E (eIF4E) is overexpressed in cervical cancer (CC). However, the molecular mechanisms are unclear. This study aimed to investigate the molecular mechanism of eIF4E gene overexpression in CC.
Introduction
Cervical cancer (CC) is one of the most common female cancers (1, 2) , which is closely related to human papillomavirus (HPV) infection. Among the molecules encoded by the high risk HPV DNAs, E7 plays a key role in carcinogenesis. E7 binds the retinoblastoma (Rb) protein family members (pRb, P107, P130) and degrades Rb proteins through the ubiquity 26S protease pathway (3, 4) . The Rb degradation leads to the release of elongation 2 factors (E2F) and the activation of proteins which are associated with DNA synthesis and promotes DNA replication, cell division and transformation (5) .
Eukaryotic translation initiation factor (eIF4E) is a rate-limiting molecule in the cap-dependent translation initiation (6) . Human eIF4E gene is located at chromosome 4q21-q25 and encodes a 24KD protein. EIF4E appears as a cap-binding protein (CBP) that recognizes explicitly the mRNA cap and regulates the mRNA translation. Studies revealed that eIF4E works as a key node of the signal pathway of carcinogenesis and tumor development (7) (8) (9) . EIF4E was overexpressed in various tumors, including breast cancer, head and neck squamous cell carcinoma, and bile duct cancer (10) (11) (12) . eIF4E also promotes tumor occurrence, invasion and metastasis by strengthening the translational expression of oncogenes and growth factors such as cellular homolog of the retroviral v-myconcogene (cMyc), vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP9) (10) (11) (12) . However, the molecular mechanism for eIF4E overexpression remains poorly studied in cervical cancer.
Recent studies reported that eIF4E protein overexpresses in CC (13) (14) (15) . However, little is known on eIF4E regulation. Van Tranppen et al (13) observed eIF4E over expression in CC tissues by reverse transcription-polymerase chain reaction (RT-PCR) and speculated that eIF4E might take a great part in tumor development. Lee et al (14) further showed through immunohistochemistry (IHC) that eIF4E expression was markedly enhanced following the progression of cervical malignant lesions. So far, studies on eIF4E in CC are still rare, leading to poor understanding of the role and regulation of eIF4E in CC. In our previous study, we found the overexpression of eIF4E was correlated to CC development (15) . However, whether HPV E7 could induce eIF4E expression is not known yet, which is an important missing point to clarify the full role of HPV and eIF4E in CC. This paper aimed to explore the mechanism of eIF4E gene overexpression in CC. Here, we provided evidence that E7 can induce eIF4E gene transcription in CC.
Materials and Methods

Cell lines and transfection
Two CC cell lines, HPV positive HeLa and HPV negative C33A were utilized. The cells were cultured in Roswell Park Memorial Institute (RPMI) cell culture medium 1640, which contains 10% Fetal Bovine Serum (FBS), 2 mmol/l l-glutamine, 50 U penicillin and 50 microgram/ml streptomycin) at 37 °C in 5% CO 2 in air.
Liposome method was employed for the plasmid transfection. Cells were divided into three groups: Mock group (untreated group, no plasmid was used for the transfection), NC group (negative control group, the plasmid containing a negative DNA fragment was used for the transfection) and treated group (the plasmid containing a tested DNA fragment was used for the transfection). 2.5 µl Lipofectamine™ 2000 (Invitrogen, G u a n g z h o u , C h i n a ) was used per microgram DNA (15) .
eIF4E immunocytochemistry (ICC)
ICC was performed using mAbs specific for eIF4E (Santa Cruz, California, USA). The primary antibody eIF4E in 1:25 dilutions was added to the cell smears and incubated at 4 °C overnight. PBS instead of the eIF4E antibody was used as the negative control staining. Plasmids shE7 RNA interference plasmids were constructed by Genechem Company, Shanghai. Three pairs of shE7 sequences were: ShE7-1 (stem:GCATGGACCTAAGG-CAACA, Loop:AGTGAAGCCACAGATGTA, stem: TGTT-GCCTTAGGTCCATGC), ShE7-2 (stem: GGCAACA-TTGCAAGACATT, Loop:AGTGAAGCCACAGATGTA, stem: AATGTCTTGCAATGTTGCC), ShE7-3(stem:GC-AAGACATTGTATTGCAT, Loop:AGTGAAGCCACAGA-TGTA, Stem:ATGCAATACAATGTCTTGC). E7 and E7 mutant expression plasmids were constructed with pEGFP-C5 vector as described previously (16) . E7 contains the wild type E7 of HPV16. E7 mutant contains mutations (TTCGGTTG to TACGTAGG) from nt 191 to nt 198 of E7. The sieIF4E was received as desalted and unprotected oligonucleotides.
The sequences of sieIF4E were: 5'-GGAUAUUAU-AAAUAGAUUATT-3' and 5'-UAAUCUAUUUAUAA-UAUCCTT-3'. Normal control (NC) sequences were: 5'-UUCUCCGAACGUGUCACGUTT-3' and 5'-ACGUGACACGUUCGGAGAATT-3'.
Detection of E7 and eIF4E mRNA by RT-PCR and real time PCR E7, eIF4E and GAPDH primer sequences were used for RT-PCR and real-time PCR: 5'-GCGTTAGAGCCCCAAAATGA-3', 5'-CGTCGGGCTGG-TAAATGTTGA-3' for E7. 5'-CTGCGGCTGATCTCCAA-G-3', 5'-CTGCGGCTGATCTCCAAG-3' for EIF4E. 5'-GAAGGTCGGAGTCAACGGATTT-3', 5'-CCTGGAAGAT-GGTGATGGGATT-3' for glyceraldehyde-3-phosphate dehydrogenase (GAPDH). RT-PCR was performed using the Access RT-PCR kit (Promega, USA) according to the manufacturer's protocols. Data was analyzed by sequence detection software from Applied Biosystems. Real-time PCR was performed by Fast Start Universal SYBR Green Master (ROX) assay on the Gene Amp PCR System 9700 (ABI company, USA).
CCK-8 cell proliferation assay
Cell proliferation was determined with Cell counting Kit-8 (CCK-8) (Beyotime Institute of Biotechnology, Shanghai, China) Assay. Cell proliferation ability was represented by the mean absorbance value (AV). The proliferation rate and inhibition rate were calculated: proliferation rate (%) = (AV treated group/AV mock -1)×100%. Inhibition rate (%)= (1-AV treated group/AV mock) ×100%.
Cell cycle assays and apoptosis assay
Cell cycle and apoptosis were evaluated by flow cytometry. 3×10 5 cells in 300 μl PBS were stained with 3 μl PI at 4 °C for 30 min in cell cycle assay, and with 3 μl Annexin V-FITC at room temperature for 10 min. The samples were analyzed with MultiCycle software using the flow cytometer BD FACS CantoTM (Becton Dickinson, CA, USA).
Transwell migration assay
Cell migration was determined in a transwell system. 6×10 4 cells were vaccinated into the upper surface of the transwell membrane and cultured at 37°C in 5% CO 2 in air for 24 hr, 48 hr and 72 hr. The number of migrated cells was counted under a microscope (200X).
Statistical analysis
Data were analyzed using SPSS 17.0 software and were reported as means±standard deviation (SD). Independent samples t-test was used for analyzing the two groups and one-way analysis of variance (ANOVA) was used for examining multiple groups. The level of statistical significance was set at P <0.05 or P <0.01.
Results
HPV E7 induced eIF4E expression and promoted the proliferation and migration of HPV negative C33A cells
The E7 expression vector was transfected into C33A cells. For RT-PCR results, two bands with expected sizes for E7 (271bp) ( Figure 1A ), E7 mutant (271bp) and GAPDH (224bp) were seen. The eIF4E mRNA detection showed two bands for eIF4E (132bp) and GAPDH (224bp) ( Figure 1B) . By Image J analysis, the relative eIF4E mRNA levels (eIF4E/GAPDH) were 0.682 (mock), 0.613 (NC), 0.808 (E7m group) and 0.762 (E7 group). The eIF4E bands were stronger in E7 and E7m groups than the mock and NC groups. The changes of the eIF4E mRNA were consistent with the changes of E7 mRNA. The lighter changes of the eIF4E mRNA in E7m group suggested that the E7m had a part of function in inducing eIF4E transcription. The results of real-time PCR were similar to that of RT-PCR.
The cell proliferation in the mock and NC groups was similar. Compared with the NC group, the proliferation rates increased by 44.3% (24 hr), 97.4% (48 hr) and 96.0% (72 hr) in E7 group, and 32.4% (24 hr), 19.9% (48 hr) and 40.5% (72 hr) in E7m group, respectively ( Figure 1C) . Here, E7m also influenced the cell proliferation, suggesting E7m maintained partial function of E7.
At any time point, the number of migrating cells in the mock and NC groups was similar. Compared with the NC group, the number of the migrating cells significantly increased by 412.01±21.523 (24 hr), 680.25±40.032 (48 hr) and 900.11±63.22(72 hr), respectively, in the E7 group, and significantly increased by 400.14±29.218 (24 hr), 651.23± 40.036(48 hr) and 850.99±51.001 (72 hr), respectively, in the E7m group ( Figure 1D ).
E7 mRNA expression was knocked down effectively by the shE7s in HeLa cells
The shE7 vectors carrying GFP were successfully constructed. The E7 mRNA level in the NC group was similar with that in the mock group, determined by both real-time PCR and RT-PCR test. By the real-time PCR detection, the E7 mRNA in shE7-1, 2, 3 treated groups were significantly lower than that of the NC group (Figure 2A ). Among shE7-1, 2, 3, shE7-2 showed the most effective inhibition of E7 mRNA, with an inhibition rate of approximately 81%. By the RT-PCR and agarose gel detection, two distinct bands with expected sizes were seen for E7 gene (119bp) and GAPDH gene (224 bp) in all groups ( Figure 2B ). By Image J band analysis, the E7 mRNA in shE7-1 and shE7-2 but not shE7-3 groups was considerably knocked down, compared with the NC group. The E7 mRNA level in shE7-2 group was lower than that in shE7-1 group ( Figure 2B ). The changes of the E7 mRNA were comparable in both the real-time PCR and RT-PCR detection (Figure 2 ). 
E7 knockdown down regulated eIF4E expression in HPV + HeLa cells
The eIF4E mRNA level in the NC group was analogous to that in the mock group, by both real-time PCR and RT-PCR detection. EIF4E mRNA levels in shE7-1, 2, 3 treated groups were significantly decreased, compared with the NC group. Among the treated groups, the eIF4E mRNA level in shE7-2 group was reduced most, with an inhibition rate of approximately 73% ( Figure 2C ). By RT-PCR and agarose gel detection, two discrete bands with expected sizes were seen for eIF4E gene (132 bp) and GAPDH gene (224 bp) ( Figure 2D ). By Image J band analysis, the eIF4E mRNA levels of shE7-1 and shE7-2 but not shE7-3 groups were substantially decreased, compared with the NC group. The eIF4E mRNA in shE7-2 group was decreased more than that in shE7-1 group. The changes of eIF4E mRNA were comparable in both the real-time PCR and RT-PCR detection. The changes of eIF4E mRNA followed tightly the changes of E7 mRNA in shE7-1, 2, 3 groups.
Using immunocytochemistry, the eIF4E protein expression was detected in HeLa cells ( Figure 2E ). The eIF4E positive cells were stained yellow brown in cytoplasm and/or nucleus. In the NC group, the rate of eIF4E positive cells was up to 96.8%. When shE7-2 transfection was done for 24 hr and 48 hr, the rates of eIF4E positive cells were decreased to 91.26% and 42.97% (P<0.001), respectively. The intensity of cell staining became considerably weaker in the shE7-2 treated group than in the NC group.
shE7-2 inhibited proliferation, migration and promoted cell apoptosis
After shE7-2 transfection, cell proliferation was significantly inhibited in shE7-2 group. The inhibition rates of cell proliferation were 9.9% (24 hr), 17.3% (48 hr) and 11.3% (72 hr) ( Figure 3A) .
Under the condition of high E7 expression, sieIF4E significantly inhibited the proliferation of the HeLa cells, to a degree comparable with the effect of shE7s. Compared with the NC group, the cell proliferation in sieIF4E group was markedly inhibited. The changes of the inhibition rates of cell proliferation in sieIF4E group were 7.635±1.143%(24 hr), 27.505±1.679% (48 hr) and 32.143±3.031% (72 hr), close to that in shE7 group at 24 hr, but significantly higher than that in shE7 group at 48 hr and 72 hr ( Figure 3B) .
Compared with the NC group, the cell cycle in shE7-2 group was noticeably changed ( Table 1) . The cell numbers were significantly increased by 14.4% (24 hr), 19.8% (48 hr) and 25.7% (72 hr) in G0/G1 phase, decreased by 15.1% (24 hr), 23.2% (48 hr) and 28.3% (72 hr) in S phase, and changed without significance in G2/M phase. The transfection effect suggested that shE7-2 inhibits the proliferation of HeLa cells through arresting cells at G0/G1 phase.
Annexin V-FITC/PI double staining method was adopted for cell apoptosis detection after the shE7-2 transfection ( Table 2 ). The change of apoptosis between the mock and NC groups was similar. Compared with the NC group, the V-FITC+/PI-cells (early apoptosis cells) in shE7-2 group were significantly increased by 30.1% (24 hr) and 39.2% (48 hr), respectively, while the V-FITC+/PI+ cells (late apoptosis cells) were increased without significance. To analyze the migration of HeLa cells after the shE7 transfection, Transwell Migration Assay was performed ( Figure 3C ). The cell numbers of migration were comparable between the mock and NC groups. Compared with the NC group, the cell numbers of migration in shE7-2 group were decreased by 33.47±11.563 (24 hr), 61.25±6.629 (48 hr), and 131.68±11.051 (72 hr), respectively (P<0.01) (Figure 3) .
Discussion
This study discovered that E7 induced eIF4E expression in CC cells. Here, the ecto-E7 gene expression significantly induced eIF4E transcriptional gene expression in C33A cells (HPV -, eIF4E + ). Furthermore, the decreased expression of eIF4E mRNA and protein directly followed the knockdown of E7 in HPV positive HeLa cells; the degree of eIF4E down regulation correspondingly matched the degree of E7 knockdown in the shE7-1, 2, 3 transfection groups of HeLa cells. To the best of our knowledge, this is the first study to suggest that E7 induces eIF4E transcription independently. This could be one of the mechanisms for eIF4E gene overexpression in CC.
However, whether E7 induces eIF4E transcription directly or indirectly is not yet known. Additional study will be done in our laboratory to confirm this issue. Evidence revealed that the conserved sequence of E7 could bind pRb, P107 and P130 (17) (18) (19) (20) . These Rb family members can form the pRb/E2F complex and inactivate the transcription and function of c-Myc, which negatively regulates the progression of G1/S and prohibits the cell cycle. In the process, E7 binds G1-specific pRb to obstruct the formation of the pRb/E2F complex and rescue the transcription and function of c-Myc, leading to the accelerated cell cycle. It was reported that the transcription of eIF4E is induced by c-Myc via a positive eIF4E/c-Myc feedback loop in lymphangiectasis (21) . As a result, we concluded that E7 up regulates eIF4E through pRb/c-Myc pathway.
The results suggested that E7 enhanced the cell proliferation, migration and cell cycle progression, and also inhibited cell apoptosis through eIF4E. E7 regulates the transcription of a series of oncogenes by complicated molecular mechanisms (16, (22) (23) (24) . Since eIF4E directly enhances the translation of many oncogenes whose gene transcription was regulated by E7, the E7/eIF4E pathway might be efficient for E7 to initiate and promote CC. However, a few studies reported the effects of eIF4E on CC cell biology. Here, ecto-E7 gene expression was performed in C33A cells to investigate the function of E7 on eIF4E. We found that up-regulation of eIF4E gene expression by E7 accelerated the cell proliferation and inhibited the apoptosis (Figure 1) . In HPV + HeLa cells, shE7 down regulated eIF4E gene expression, inhibited the cell proliferation and speeded up the cell apoptosis (Figure 3) . These results indicate that eIF4E engaged in the key process of HPV caused carcinogenesis.
In addition, HPV E6 and E7 are proven to produce a bicistronic transcript. Thus, the knockdown of E7 might also lead to the knockdown of E6 gene (25, 26) . In this study, we knocked down E7 in HPV + HeLa cells. The results showed down regulation of eIF4E gene expression and the cell proliferation. This result may be caused by single E7 or E6/E7 because of the presence of the E6/E7 bicistronic transcript. Thus, HPV -C33A cells were chosen to demonstrate the ability of E7 gene affecting eIF4E. After the E7 expression vector was transfected into C33A cells, the expression of E7 up-regulated eIF4E markedly in the absence of E6. The result showed clearly that E7 could induce eIF4E gene transcription. Thus, the down-regulation of eIF4E was caused, at least, mainly by the knockdown of E7. We concluded that E7 could induce eIF4E in HeLa and C33A cells.
Conclusion
EIF4E gene overexpression in CC cell lines was further confirmed in this study. More importantly, we discovered that the transcription of eIF4E could be induced by HPV E7. In addition, the down regulation or up regulation of eIF4E on the condition of sustained high expression of E7 significantly influenced the cell proliferation, cell cycle progression, migration and apoptosis. Our finding suggests that eIF4E is an important target for the treatment and prevention of HPV associated cancers such as CC.
